spacer
spacer

PDBsum entry 1n0s

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Binding protein PDB id
1n0s

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
173 a.a. *
Ligands
FLU ×2
SO4
Waters ×98
* Residue conservation analysis
PDB id:
1n0s
Name: Binding protein
Title: Engineered lipocalin flua in complex with fluorescein
Structure: Bilin-binding protein. Chain: a, b. Synonym: bbp, anticalin flua. Engineered: yes
Source: Pieris brassicae. Large cabbage white. Organism_taxid: 7116. Expressed in: escherichia coli. Expression_system_taxid: 562.
Resolution:
2.00Å     R-factor:   0.196     R-free:   0.243
Authors: I.P.Korndoerfer,A.Skerra
Key ref:
I.P.Korndörfer et al. (2003). Crystallographic analysis of an "anticalin" with tailored specificity for fluorescein reveals high structural plasticity of the lipocalin loop region. Proteins, 53, 121-129. PubMed id: 12945055 DOI: 10.1002/prot.10497
Date:
15-Oct-02     Release date:   05-Aug-03    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P09464  (BBP_PIEBR) -  Bilin-binding protein from Pieris brassicae
Seq:
Struc:
189 a.a.
173 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 21 residue positions (black crosses)

 

 
DOI no: 10.1002/prot.10497 Proteins 53:121-129 (2003)
PubMed id: 12945055  
 
 
Crystallographic analysis of an "anticalin" with tailored specificity for fluorescein reveals high structural plasticity of the lipocalin loop region.
I.P.Korndörfer, G.Beste, A.Skerra.
 
  ABSTRACT  
 
The artificial lipocalin FluA with novel specificity toward fluorescein was derived via combinatorial engineering from the bilin-binding protein, BBP by exchange of 16 amino acids in the ligand pocket. Here, we describe the crystal structure of FluA at 2.0 A resolution in the space group P2(1) with two protein-ligand complexes in the asymmetric unit. In both molecules, the characteristic beta-barrel architecture with the attached alpha-helix is well preserved. In contrast, the four loops at one end of the beta-barrel that form the entrance to the binding site exhibit large conformational deviations from the wild-type protein, which can be attributed to the sidechain replacements. Specificity for the new ligand is furnished by hydrophobic packing, charged sidechain environment, and hydrogen bonds with its hydroxyl groups. Unexpectedly, fluorescein is bound in a much deeper cavity than biliverdin IX(gamma) in the natural lipocalin. Triggered by the substituted residues, unmutated sidechains at the bottom of the binding site adopt conformations that are quite different from those observed in the BBP, illustrating that not only the loop region but also the hydrophobic interior of the beta-barrel can be reshaped for molecular recognition. Particularly, Trp 129 participates in a tight stacking interaction with the xanthenolone moiety, which may explain the ultrafast electron transfer that occurs on light excitation of the bound fluorescein. These structural findings support our concept of using lipocalins as a scaffold for the engineering of so-called "anticalins" directed against prescribed targets as an alternative to recombinant antibody fragments.
 
  Selected figure(s)  
 
Figure 2.
Figure 2. The two monomers of FluA in the asymmetric crystal unit. Each polypeptide chain is shown in a ribbon presentation, light- and dark-gray, respectively, with its N- and C-terminus labeled and the fluorescein ligand depicted as a ball-and-stick model. The intermolecular -sheet that is formed via association of the loop #3 segments from the two monomers can be seen at the middle, together with the position of the crystallographically fixed sulfate ion.
Figure 4.
Figure 4. Stereo images with details of the novel ligand-binding site in FluA. (A) 2F[o]-F[c] electron density for the bound fluorescein contoured at 1.0 , together with sidechains of residues closer than 3.8 Å. Amino acids that were mutated in FluA (cf. Fig. 1) are colored dark-green, whereas original residues of BBP are depicted in light-green. (B) The set of 16 randomly mutated sidechains in the FluA crystal structure with the complexed fluorescein. (C) Arrangement of positively charged residues at the entrance to the ligand pocket of FluA. The three characteristically arranged Arg side chains (see text) are colored dark-blue. Note that there is a considerable distance between Arg 95 - whose sidechain is well defined in the electron density - and the bound fluorescein along the view axis (distance between the guanidinium and carboxylate groups: 8.6 Å) such that no direct contact is formed.
 
  The above figures are reprinted by permission from John Wiley & Sons, Inc.: Proteins (2003, 53, 121-129) copyright 2003.  
  Figures were selected by the author.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
  20944205 H.J.Chiu, C.Bakolitsa, A.Skerra, A.Lomize, D.Carlton, M.D.Miller, S.S.Krishna, P.Abdubek, T.Astakhova, H.L.Axelrod, T.Clayton, M.C.Deller, L.Duan, J.Feuerhelm, J.C.Grant, S.K.Grzechnik, G.W.Han, L.Jaroszewski, K.K.Jin, H.E.Klock, M.W.Knuth, P.Kozbial, A.Kumar, D.Marciano, D.McMullan, A.T.Morse, E.Nigoghossian, L.Okach, J.Paulsen, R.Reyes, C.L.Rife, H.van den Bedem, D.Weekes, Q.Xu, K.O.Hodgson, J.Wooley, M.A.Elsliger, A.M.Deacon, A.Godzik, S.A.Lesley, and I.A.Wilson (2010).
Structure of the first representative of Pfam family PF09410 (DUF2006) reveals a structural signature of the calycin superfamily that suggests a role in lipid metabolism.
  Acta Crystallogr Sect F Struct Biol Cryst Commun, 66, 1153-1159.
PDB code: 2ich
19603796 J.L.Mills, G.Liu, A.Skerra, and T.Szyperski (2009).
NMR structure and dynamics of the engineered fluorescein-binding lipocalin FluA reveal rigidification of beta-barrel and variable loops upon enthalpy-driven ligand binding.
  Biochemistry, 48, 7411-7419.
PDB code: 1t0v
18435758 A.Skerra (2008).
Alternative binding proteins: anticalins - harnessing the structural plasticity of the lipocalin ligand pocket to engineer novel binding activities.
  FEBS J, 275, 2677-2683.  
18940670 B.Krishnan, and L.M.Gierasch (2008).
Cross-strand split tetra-Cys motifs as structure sensors in a beta-sheet protein.
  Chem Biol, 15, 1104-1115.  
18391216 J.Wiedersich, S.Köhler, A.Skerra, and J.Friedrich (2008).
Temperature and pressure dependence of protein stability: the engineered fluorescein-binding lipocalin FluA shows an elliptic phase diagram.
  Proc Natl Acad Sci U S A, 105, 5756-5761.  
20477155 A.M.Hohlbaum, and A.Skerra (2007).
Anticalins: the lipocalin family as a novel protein scaffold for the development of next-generation immunotherapies.
  Expert Rev Clin Immunol, 3, 491-501.  
17023486 C.Kiss, H.Fisher, E.Pesavento, M.Dai, R.Valero, M.Ovecka, R.Nolan, M.L.Phipps, N.Velappan, L.Chasteen, J.S.Martinez, G.S.Waldo, P.Pavlik, and A.R.Bradbury (2006).
Antibody binding loop insertions as diversity elements.
  Nucleic Acids Res, 34, e132.  
16373474 R.J.Hosse, A.Rothe, and B.E.Power (2006).
A new generation of protein display scaffolds for molecular recognition.
  Protein Sci, 15, 14-27.  
16195545 A.Honegger, S.Spinelli, C.Cambillau, and A.Plückthun (2005).
A mutation designed to alter crystal packing permits structural analysis of a tight-binding fluorescein-scFv complex.
  Protein Sci, 14, 2537-2549.
PDB codes: 2a9m 2a9n
15734741 D.L.Stokes, F.Delavoie, W.J.Rice, P.Champeil, D.B.McIntosh, and J.J.Lacapère (2005).
Structural studies of a stabilized phosphoenzyme intermediate of Ca2+-ATPase.
  J Biol Chem, 280, 18063-18072.  
16005204 H.K.Binz, and A.Plückthun (2005).
Engineered proteins as specific binding reagents.
  Curr Opin Biotechnol, 16, 459-469.  
16211069 H.K.Binz, P.Amstutz, and A.Plückthun (2005).
Engineering novel binding proteins from nonimmunoglobulin domains.
  Nat Biotechnol, 23, 1257-1268.  
16131659 K.Deuschle, S.Okumoto, M.Fehr, L.L.Looger, L.Kozhukh, and W.B.Frommer (2005).
Construction and optimization of a family of genetically encoded metabolite sensors by semirational protein engineering.
  Protein Sci, 14, 2304-2314.  
16207069 S.Schlehuber, and A.Skerra (2005).
Anticalins in drug development.
  BioDrugs, 19, 279-288.  
16255649 S.Schlehuber, and A.Skerra (2005).
Anticalins as an alternative to antibody technology.
  Expert Opin Biol Ther, 5, 1453-1462.  
16307475 S.Vopel, H.Mühlbach, and A.Skerra (2005).
Rational engineering of a fluorescein-binding anticalin for improved ligand affinity.
  Biol Chem, 386, 1097-1104.  
15313246 P.Mathonet, and J.Fastrez (2004).
Engineering of non-natural receptors.
  Curr Opin Struct Biol, 14, 505-511.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer